Microbix Biosystems, Seegene Mexico collaborate to improve test accuracy

Microbix Biosystems (MBXBF) and Seegene Mexico S.A.P.I. de C.V. announce that Microbix external third-party quality assessment products will be used to support the clinical use of the Allplex and Anyplex molecular multiplex assays of Seegene Mexico for detecting infection with high-risk types of the human papilloma virus. David Choi, CEO at Seegene Mexico, commented, “We believe that expanding access to Seegene’s Allplex and Anyplex HPV tests across Mexico will substantially improve public-health efforts for cervical cancer surveillance. We’re pleased to collaborate with Microbix and its REDx and PROCEEDx brand QAPs to ensure the smooth implementation and broad adoption of our assays. Seegene remains committed to supporting clinical laboratories through continuous training and strengthening their quality management systems, not only for HPV testing but also for the diagnosis of a wide range of infectious diseases.”